Last updateFri, 03 Jul 2020 5pm

Back You are here: Inicio Biology & biomedicine Projects

Proyecto público-privado para desarrollar una terapia contra la aterosclerosis

There is no translation available.

El objetivo es validar una nueva familia de candidatos a fármacos para el tratamiento de la acumulación vascular de colesterol asociada a la aterosclerosis. Está liderado por la biotecnológica Iproteos, con sede en el Parc Científic de Barcelona, y participan el Instituto de Investigaciones Biomédicas de Barcelona (IIBB) del CSIC y el Centro de Regulación Genómica (CRG) de Barcelona.

Read more ...

Molecules activated by light

The molecules that change their form when they receive light have opened the door to the so called photo-activated drugs. The change of structure makes them bind together and recognize  biological receptors and, therefore, to activate or deactivate them. At the CSIC’s Institute of Advanced Chemistry, scientists are working to develop these types of molecules which can be applied to biomedicine.

Read more ...

A novel targeted anticancer therapy system based on carbon nanocapsules

Researchers from the Materials Science Institute of Barcelona (ICMAB-CSIC) in collaboration with the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Institute of Molecular and Cellular Biology (IBMC-CNRS) and King’s College London (KCL) have developed a novel nanocarrier anti-cancer platform for the targeted delivery of radioactivity.

Read more ...

Chaos as a strategy

A study analyzes the search strategy for food used by a marine snail. It is based on chaotic turns and movements. This search pattern, could be useful for search applications (drons, people rescue…) when there is no clear sign of the item that has to be found.

Read more ...

Award for the bioreactor that simulates the liver

The project "Liver on a chip", participated by the Biomedical Applications Group of the IMB-CNM (CSIC), won the second prize of the second Vall d’Hebron Research Institute (VHIR) Health Innovation Contest in the Biomedical Research Innovation category.

Read more ...